Botulinum  	Botulinum  	 JJ	B-NP
toxin  	toxin  	 NN	I-NP
A 	A 	 NN	O
:  	:  	 :	O
is  	is  	 VBZ	O
it  	it  	 PRP	O
really  	really  	 RB	O
that  	that  	 IN	O
fragile  	fragile  	 VBG	O
a  	a  	 DT	O
molecule 	molecule 	 NN	B-NP
?  	?  	 .	O
Botulinum  	Botulinum  	 JJ	B-NP
toxin  	toxin  	 NN	I-NP
A  	A  	 DT	O
is  	is  	 VBZ	O
considered  	considered  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
an  	an  	 DT	O
extremely  	extremely  	 RB	O
fragile  	fragile  	 JJ	O
molecule 	molecule 	 NN	B-NP
,  	,  	 ,	O
with  	with  	 IN	O
recommended  	recommended  	 JJ	O
usage  	usage  	 NN	O
of  	of  	 IN	O
some  	some  	 DT	O
reconstituted  	reconstituted  	 JJ	B-NP
botulinum  	botulinum  	 JJ	I-NP
toxin  	toxin  	 NN	I-NP
A  	A  	 DT	O
formulations  	formulations  	 NN	B-NP
within  	within  	 IN	O
4  	4  	 CD	O
hours  	hours  	 NNS	O
of  	of  	 IN	O
reconstitution 	reconstitution 	 NN	B-NP
.  	.  	 .	O
Extreme  	Extreme  	 JJ	O
caution  	caution  	 NN	O
is  	is  	 VBZ	O
recommended  	recommended  	 VBN	O
to  	to  	 TO	O
avoid  	avoid  	 VB	O
agitation  	agitation  	 VBN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
vial 	vial 	 NN	O
.  	.  	 .	O
To  	To  	 TO	O
determine  	determine  	 VB	O
whether  	whether  	 IN	O
the  	the  	 DT	O
effect  	effect  	 NN	O
of  	of  	 IN	O
reconstituted  	reconstituted  	 JJ	B-NP
botulinum  	botulinum  	 JJ	I-NP
toxin  	toxin  	 NN	I-NP
A  	A  	 DT	O
is  	is  	 VBZ	O
maintained  	maintained  	 VBN	O
even  	even  	 RB	O
when  	when  	 WRB	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
agitated  	agitated  	 VBN	O
vigorously 	vigorously 	 RB	O
.  	.  	 .	O
Experimental 	Experimental 	 NNP	O
,  	,  	 ,	O
comparative 	comparative 	 JJ	O
,  	,  	 ,	O
animal  	animal  	 JJ	O
study 	study 	 NN	O
.  	.  	 .	O
Sixty-four  	Sixty-four  	 JJ	O
white  	white  	 JJ	O
Swiss  	Swiss  	 JJ	O
Webster  	Webster  	 NNP	O
mice 	mice 	 NNS	O
,  	,  	 ,	O
aged  	aged  	 VBN	O
2  	2  	 CD	O
to  	to  	 TO	O
4  	4  	 CD	O
weeks 	weeks 	 NNS	O
,  	,  	 ,	O
arranged  	arranged  	 VBN	O
in  	in  	 IN	O
eight  	eight  	 CD	O
separate  	separate  	 JJ	O
groups 	groups 	 NNS	O
.  	.  	 .	O
Reconstituted  	Reconstituted  	 NNP	O
onabotulinumtoxinA  	onabotulinumtoxinA  	 NNP	B-NP
( 	( 	 -LRB-	O
2.5  	2.5  	 CD	O
U 	U 	 NNP	O
/ 	/ 	 CD	O
0.1  	0.1  	 CD	O
mL 	mL 	 NN	O
)  	)  	 -RRB-	O
was  	was  	 VBD	O
placed  	placed  	 VBN	O
securely  	securely  	 RB	O
in  	in  	 IN	O
a  	a  	 DT	O
battery-operated  	battery-operated  	 JJ	O
mechanized  	mechanized  	 JJ	O
apparatus 	apparatus 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
apparatus  	apparatus  	 NN	B-NP
with  	with  	 IN	O
the  	the  	 DT	O
vial  	vial  	 NN	O
was  	was  	 VBD	O
placed  	placed  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
refrigerator 	refrigerator 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
apparatus  	apparatus  	 NN	B-NP
continuously  	continuously  	 RB	O
inverted  	inverted  	 VBN	O
and  	and  	 CC	O
straightened  	straightened  	 VBG	O
the  	the  	 DT	O
onabotulinumtoxinA  	onabotulinumtoxinA  	 JJ	B-NP
vial  	vial  	 NN	I-NP
30  	30  	 CD	O
times  	times  	 NNS	O
a  	a  	 DT	O
minute 	minute 	 NN	O
.  	.  	 .	O
Eight  	Eight  	 CD	O
mice  	mice  	 NNS	O
were  	were  	 VBD	O
each  	each  	 DT	O
injected  	injected  	 JJ	O
intraperitoneally  	intraperitoneally  	 NN	O
with  	with  	 IN	O
1  	1  	 CD	O
U  	U  	 NNP	O
of  	of  	 IN	O
the  	the  	 DT	O
agitated  	agitated  	 JJ	O
onabotulinumtoxinA  	onabotulinumtoxinA  	 NN	B-NP
on  	on  	 IN	O
days  	days  	 NNS	O
1 	1 	 CD	O
,  	,  	 ,	O
3 	3 	 CD	O
,  	,  	 ,	O
5 	5 	 CD	O
,  	,  	 ,	O
7 	7 	 CD	O
,  	,  	 ,	O
14 	14 	 CD	O
,  	,  	 ,	O
21 	21 	 CD	O
,  	,  	 ,	O
28 	28 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
42 	42 	 CD	O
,  	,  	 ,	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
the  	the  	 DT	O
efficacy  	efficacy  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
continuously  	continuously  	 JJ	O
agitated  	agitated  	 JJ	O
onabotulinumtoxinA 	onabotulinumtoxinA 	 NN	B-NP
.  	.  	 .	O
Death  	Death  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
mice 	mice 	 NNS	O
,  	,  	 ,	O
demonstrating  	demonstrating  	 VBG	B-NP
efficacy  	efficacy  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
onabotulinumtoxinA  	onabotulinumtoxinA  	 JJ	I-NP
molecule 	molecule 	 NN	I-NP
.  	.  	 .	O
Half  	Half  	 NN	O
of  	of  	 IN	O
each  	each  	 DT	O
group  	group  	 NN	O
of  	of  	 IN	O
mice  	mice  	 NNS	O
( 	( 	 -LRB-	O
4 	4 	 CD	O
/ 	/ 	 CD	O
8  	8  	 CD	O
mice 	mice 	 NNS	O
)  	)  	 -RRB-	O
died  	died  	 VBD	O
within  	within  	 IN	O
48  	48  	 CD	O
hours  	hours  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
injection  	injection  	 NN	B-NP
( 	( 	 -LRB-	O
range  	range  	 NN	O
16-48  	16-48  	 CD	O
hours 	hours 	 NNS	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
effect  	effect  	 NN	O
of  	of  	 IN	O
botulinum  	botulinum  	 JJ	B-NP
toxin  	toxin  	 NN	I-NP
type  	type  	 NN	I-NP
A  	A  	 DT	O
is  	is  	 VBZ	O
maintained  	maintained  	 VBN	O
even  	even  	 RB	O
when  	when  	 WRB	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
agitated  	agitated  	 VBN	O
vigorously  	vigorously  	 RB	O
for  	for  	 IN	O
up  	up  	 RB	O
to  	to  	 TO	O
6  	6  	 CD	O
weeks 	weeks 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
authors  	authors  	 NNS	O
have  	have  	 VBP	O
indicated  	indicated  	 VBN	O
no  	no  	 DT	O
significant  	significant  	 JJ	O
interest  	interest  	 NN	O
with  	with  	 IN	O
commercial  	commercial  	 JJ	B-NP
supporters 	supporters 	 NNS	I-NP
.  	.  	 .	O
